Despite this, FGFR inhibitors are effective at killing FGFR-TACC-expressing cells in vitro and prolong survival of mice bearing FGFR3-TACC3-induced tumours in vivo, suggesting the TK activity is important. Here, FGFR3 is linked to neoplasm.